This Article Full Text Full Text (PDF) All Versions of this Article: chest.07-1948v1 133/1/226    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Google Scholar Articles by Kinder, B. W. Articles by King, T. E. PubMed PubMed Citation Articles by Kinder, B. W. Articles by King, T. E., Jr

Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis^*

^* From the Department of Medicine (Dr. Kinder), University of Cincinnati College of Medicine, Cincinnati, OH; the Department of Medicine (Drs. Brown, Schwarz, and Kervitsky), National Jewish Medical and Research Center, Denver, CO; the Department of Medicine (Dr. Ix), University of California San Diego, San Diego, CA; and the Department of Medicine (Dr. King), University of California San Francisco School of Medicine, San Francisco, CA.

Correspondence to: Talmadge E. King, Jr, MD, Chair, Department of Medicine, UCSF, 505 Parnassus Ave, M-994, San Francisco, CA 94143; e-mail: tking{at}medicine.ucsf.edu

Abstract

Background: The prognostic value of BAL fluid cell count differential in patients with idiopathic pulmonary fibrosis (IPF) is unknown. We hypothesized that baseline BAL fluid cell count differential (ie, elevated levels of neutrophils and eosinophils, or reduced levels of lymphocytes) would predict higher mortality among persons with IPF.

Methods: We evaluated the association of BAL fluid cell count differential and mortality among 156 persons with surgical lung biopsy-proven IPF who underwent bronchoscopy with BAL and cell count differential measurements at presentation. Vital status was obtained among all participants. Cox regression analysis evaluated the association of BAL fluid cell count differential and mortality.

Results: After controlling for known clinical predictors of mortality, we found that each doubling of baseline BAL fluid neutrophil percentage was associated with a 30% increased risk of mortality (adjusted hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.01 to 1.62; adjusted p = 0.04) in the first year after presentation. We observed no association with BAL fluid lymphocyte percentage and mortality (adjusted HR per doubling, 0.99; 95% CI, 0.76 to 1.29; p = 0.93) or eosinophil percentage and mortality (adjusted HR per doubling, 0.99; 95% CI, 0.69 to 1.40; p = 0.95).

Conclusions: Increased BAL fluid neutrophil percentage is an independent predictor of early mortality among persons with IPF. Alternatively, BAL fluid lymphocyte and eosinophil percentages were not associated with mortality. The clinical utility of BAL at the time of diagnosis of IPF should be reconsidered.

Key Words: BAL • idiopathic pulmonary fibrosis • neutrophilia • physiopathology • prospective studies • pulmonary fibrosis • smoking • survival rate • usual interstitial pneumonia